Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine Inc. is back in the spotlight today after releasing positive top-line results from the first cohort of its FDA‑approved Phase I/IIa clinical trial for CMND‑100 in alcohol use disorder. The update lands just one day after the company highlighted a new Israeli patent filing for a non‑hallucinogenic depression therapy, and as a fresh equity offering is expected to close around today’s date. GlobeNewswire+2GlobeNewswire+2
18 November 2025
··
Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit (INTU) Stock Rises on $100M+ OpenAI Deal to Bring TurboTax and QuickBooks Into ChatGPT

Intuit Inc. is back in the AI spotlight today after unveiling a multi‑year partnership with OpenAI that will see flagship products like TurboTax, QuickBooks, Credit Karma and Mailchimp embedded directly inside ChatGPT. The company has also signed a contract worth more than $100 million to deepen its use of OpenAI’s models across its own AI platform, GenOS. Intuit Inc.+1
18 November 2025
···
Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

Temu Owner PDD Holdings Beats Profit Forecasts but Warns of Slower Growth as Stock Slides on Q3 2025 Results

Chinese e-commerce group PDD Holdings Inc., the parent of bargain-shopping apps Pinduoduo and Temu, reported third-quarter 2025 results on Tuesday that showed solid profit growth and robust cash generation — but a clear slowdown in revenue growth. That combination sent the stock lower in U.S. trading as investors weighed strong margins against a tougher competitive and regulatory backdrop. GlobeNewswire+2Reuters+2
18 November 2025
···
Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Can-Fite BioPharma (CANF) Soars on 9-Year Liver Cancer Survival Breakthrough with Namodenoson – November 18, 2025

Shares of Can-Fite BioPharma Ltd. jumped on Tuesday after the company reported a striking 9‑year overall survival with a complete response in an advanced liver cancer patient treated with its investigational drug Namodenoson, and confirmed that a pivotal Phase III trial in hepatocellular carcinoma is now enrolling patients in multiple regions. GlobeNewswire+1
18 November 2025
···
Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic plc is back in the spotlight today after reporting stronger‑than‑expected results for the second quarter of fiscal 2026 and raising its full‑year outlook. The medical technology giant delivered solid revenue and earnings growth, highlighted powerful momentum in its cardiac ablation franchise, and signaled confidence in accelerating growth in the second half of the year. Medtronic News+1
18 November 2025
···
VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

VTI vs. SCHB on November 18, 2025: What’s Moving Vanguard’s Total‑Market ETF Today—and Which “Total Stock” Fund Has the Edge?

Wall Street’s tone turned defensive into Tuesday as tech‑valuation concerns, a deepening crypto drawdown, and anticipation of Nvidia’s quarterly results stoked the highest VIX in about a month. U.S. benchmarks finished almost 1% lower on Monday and futures stayed soft before the open. That macro mix is the dominant driver for broad beta ETFs like VTI today. Reuters
18 November 2025
····
Emirates turns the screws on Boeing with $38B 777X order as it snubs Airbus A350‑1000 over engine concerns — Dubai Airshow 2025

Emirates turns the screws on Boeing with $38B 777X order as it snubs Airbus A350‑1000 over engine concerns — Dubai Airshow 2025

Emirates used day two of the Dubai Airshow to keep pressure on Boeing to execute a blockbuster $38 billion order for 65 additional 777‑9s, while dashing hopes of a fresh Airbus A350‑1000 deal until Rolls‑Royce engine upgrades arrive later this decade. The moves cement Emirates’ bet on very‑large twinjets and intensify the wide‑body dogfight between Boeing and Airbus. Emirates+2Boeing Investors+2
18 November 2025
······
Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

Stock Market Today (Nov. 18, 2025): Nasdaq slides as AI trade stumbles; Tesla, Palantir, SMCI pace tech losses ahead of Nvidia earnings; Disney ends YouTube TV blackout

Tech led the sell‑off again as investors questioned whether multi‑quarter AI capex can keep delivering near‑term returns. With Nvidia set to report Wednesday, options markets are braced for a ~7% swing that could ripple across index‑heavy tech and AI hardware/software cohorts. A move of that size would rank among the largest post‑earnings value changes ever for the company. Reuters
18 November 2025
········
Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Microsoft (MSFT) and Amazon (AMZN) Downgraded to Neutral by Rothschild & Co Redburn on AI Capex Concerns — Stocks Slip on Nov. 18, 2025

Rothschild & Co Redburn broke with the prevailing Wall Street optimism on Tuesday, cutting ratings on Microsoft and Amazon to Neutral from Buy. Analyst Alexander Haissl also lowered Microsoft’s 12‑month price target to $500 and kept Amazon’s target at $250, calling for a more cautious stance on the hyperscaler complex. The call marks Haissl’s first downgrade of the two since initiating coverage in 2022. Bloomberg+1
18 November 2025
····
Harvard’s $443 Million Bitcoin Bet Signals a New Era for University Endowments — Even as BTC Slides Below $90,000

Harvard’s $443 Million Bitcoin Bet Signals a New Era for University Endowments — Even as BTC Slides Below $90,000

Harvard University’s endowment has nearly tripled its stake in BlackRock’s iShares Bitcoin Trust to about $443 million, making Bitcoin its largest publicly disclosed U.S. holding. Emory University and sovereign wealth funds are also piling into Bitcoin ETFs — even as spot ETFs see billions in outflows and BTC falls under $90,000.
18 November 2025
··
1 … 43 44 45 46 47 … 164

Stock Market Today

  • S&P 500 May Face Turbulence Before Resuming Rally, Yardeni Research Says
    July 25, 2026, 12:18 PM EDT. Yardeni Research predicts U.S. stock market volatility in the near term prior to a return to its upward trend, reiterating its S&P 500 year-end target of 8,250. The firm highlights Middle East instability pushing oil from $72 to $95 per barrel, AI-related concerns, and threats of new tariffs. Treasury yields are climbing, pointing to a higher probability of Fed rate increases (35% in July, 55% in September). Geopolitical factors make Yardeni favor energy shares.